Suppr超能文献

肝门部胆管癌手术治疗的单中心经验

Single centre experience with surgical treatment of hilar cholangiocarcinoma.

作者信息

Vladov N, Lukanova Ts, Takorov I, Mutafchiyski V, Vasilevski I, Sergeev S, Odisseeva E

机构信息

Department of Hepato-Biliary Surgery and Transplantation, Military Medical Hospital, Sofia, Bulgaria.

出版信息

Chirurgia (Bucur). 2013 May-Jun;108(3):299-303.

Abstract

UNLABELLED

BACKGROUND /AIMS: Surgical resection is a radical treatment option for hilar cholangiocarcinomas. However it is still difficult to cure and patient prognosis is poor. An evaluation of the surgical options and results may elucidate effective treatments.

METHODOLOGY

We retrospectively examined the demographic characteristics, surgical records and outcome in 64 patients with hilar cholangiocarcinoma undergoing surgical resections or palliative surgical procedures for the period of 2004-2012.

RESULTS

The patients included 43 males and 17 females with a mean age of 61.4 ± 10.4 years (±SD, range 35-81 years). Forty four resections were done - R0-22 cases (34.4%), R1 - 10 (15.6 %) cases, R2 -12 cases (18.7%) and 20 palliative (31.3%) operations were performed. R0 - resection of common bile ducts with right hepatectomy with Sg 1 was done in 8 cases, resection of common hepatic duct with left hepatectomy with Sg 1 in 9 cases and resection of common hepatic duct in 5 cases. The total percentage of postoperative morbidity is 51.5 %. The types of complications are as follows: intra abdominal bleeding 31.25 %, temporary biliary leakage - 26.56 %, leakage of hepatico-jejunostomyâ7.81 %, biliary fistula 7.81%, liver insufficiency 17.18 %, pleural effusion 48.13 %, intraabdominal abscess 28.13 %, surgical site infection 48.3 %. The mean five-year overall survival for R0 - resection is 32%, for R1 - and R2 - resection is 12% and for the palliative operations - 0%. The mean overall survival for R0-resection is 37 months, for R1 - and R2 - resection is 19 months and for the palliative operations 7 months.

CONCLUSIONS

Radically extended surgical resection for hilar cholangiocarcinoma is necessary to obtain improved patient survival.

摘要

未标注

背景/目的:手术切除是肝门部胆管癌的一种根治性治疗选择。然而,其治愈仍很困难,患者预后较差。对手术选择和结果进行评估可能会阐明有效的治疗方法。

方法

我们回顾性研究了2004年至2012年期间64例行手术切除或姑息性手术的肝门部胆管癌患者的人口统计学特征、手术记录和预后。

结果

患者包括43例男性和17例女性,平均年龄61.4±10.4岁(±标准差,范围35 - 81岁)。共进行了44例切除术——R0切除22例(34.4%),R1切除10例(15.6%),R2切除12例(18.7%),并进行了20例姑息性手术(31.3%)。8例行右半肝切除并切除1段肝管的胆总管R0切除,9例行左半肝切除并切除1段肝管的肝总管R0切除,5例行肝总管切除。术后并发症总发生率为51.5%。并发症类型如下:腹腔内出血31.25%,暂时性胆漏26.56%,肝空肠吻合口漏7.81%,胆瘘7.81%肝衰竭17.18%,胸腔积液48.13%,腹腔脓肿28.13%,手术部位感染48.3%。R0切除的平均5年总生存率为32%,R1和R2切除为12%,姑息性手术为0%。R0切除的平均总生存期为37个月,R1和R2切除为19个月,姑息性手术为7个月。

结论

为提高患者生存率,对肝门部胆管癌进行根治性扩大手术切除是必要的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验